Define and classify anemia.

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
I now have rich, authoritative content from multiple major textbooks. Let me compile the comprehensive answer.

Anemia: Definition and Classification

Definition

Anemia is defined as a reduction of the total circulating red cell mass below normal limits, which reduces the oxygen-carrying capacity of the blood, leading to tissue hypoxia. - Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 594
In clinical practice, direct measurement of red cell mass is impractical, so anemia is diagnosed using surrogate measures:
  • Hemoglobin (Hb) concentration - preferred because it is directly measured (not calculated)
  • Hematocrit (Hct) - the ratio of packed red cells to total blood volume (calculated by electronic counters as RBC count × MCV)
  • Red blood cell count - reported but rarely used alone to define anemia
The WHO defines anemia as:
PopulationHb threshold
Adult men< 13 g/dL
Adult women (non-pregnant)< 12 g/dL
Pregnant women< 11 g/dL
Children 6-59 months< 11 g/dL
Note: hematocrit-based values may not accurately reflect red cell mass when plasma volume is altered (e.g., dehydration or fluid overload). - Goldman-Cecil Medicine, p. 1666

Classification

There are two major, complementary ways to classify anemia, both of which are clinically used together:

I. Morphologic Classification (by Red Cell Size / MCV)

Pioneered by hematologist Max Wintrobe, this scheme groups anemia by the mean corpuscular volume (MCV) and remains the most practical starting point in workup. - Harrison's Principles of Internal Medicine 22E, p. 492

A. Microcytic Anemia (MCV < 80 fL)

Caused by any process that interferes with hemoglobin synthesis - less hemoglobin = smaller cells. Cells are also typically hypochromic.
CauseMechanism
Iron deficiency anemiaInability to synthesize heme
Thalassemia syndromesDefective globin chain synthesis
Anemia of chronic disease / inflammationImpaired iron reutilization (cytokine-mediated); often normocytic
Sideroblastic anemiaDefective heme synthesis; mitochondrial iron trapping
Lead poisoningInhibits heme synthesis enzymes

B. Normocytic Anemia (MCV 80-100 fL)

A heterogeneous group; the reticulocyte count is critical to narrow the differential.
Cause
Aplastic anemia
Anemia of chronic kidney disease
Anemia of inflammation (most cases)
Endocrinopathies (hypothyroidism, adrenal insufficiency, androgen deficiency)
Early iron deficiency
Sickle cell disease (homozygous)
Bone marrow infiltration / myelodysplastic syndrome
Physiologic anemia of pregnancy

C. Macrocytic Anemia (MCV > 100 fL)

Further subdivided by red cell shape on peripheral smear:
Megaloblastic (oval macrocytes) - defects in DNA synthesis:
  • Vitamin B12 deficiency
  • Folate deficiency
  • Medications (chemotherapy agents, some antiepileptics, methotrexate)
  • Myelodysplastic syndrome
Non-megaloblastic (round macrocytes) - membrane or other defects:
  • Alcohol use disorder / liver disease
  • Hypothyroidism
  • Reticulocytosis (young RBCs are larger)
  • Dysproteinemia
  • Hypoxia, smoking
  • Harrison's Principles of Internal Medicine 22E, p. 492; Goldman-Cecil Medicine, Table 144-9

II. Pathophysiologic (Mechanistic) Classification

This scheme classifies anemia by underlying mechanism and is guided by the reticulocyte count as the key initial test:
  • High reticulocytes → bone marrow is responding = increased loss or destruction
  • Low/inappropriately normal reticulocytes → bone marrow is failing = underproduction
The three broad mechanisms are:

A. Blood Loss

TypeExamples
Acute blood lossTrauma, surgery, GI hemorrhage
Chronic blood lossGI tract lesions (peptic ulcer, colorectal cancer), gynecologic disturbances (menorrhagia)
Chronic blood loss leads secondarily to iron deficiency anemia.

B. Increased Red Cell Destruction (Hemolytic Anemia)

Characterized by elevated LDH, low haptoglobin, elevated indirect bilirubin, reticulocytosis, and characteristic peripheral smear findings.
1. Intrinsic (inherited) defects:
CategoryExamples
Red cell membrane disordersHereditary spherocytosis, hereditary elliptocytosis
Enzyme deficiencies (HMP shunt)G6PD deficiency, glutathione synthetase deficiency
Enzyme deficiencies (glycolytic)Pyruvate kinase deficiency, hexokinase deficiency
HemoglobinopathiesSickle cell disease, unstable hemoglobins
Deficient globin synthesisThalassemia syndromes
Acquired genetic defectParoxysmal nocturnal hemoglobinuria (PNH) - deficiency of GPI-linked proteins
2. Extrinsic (acquired) causes:
CategoryExamples
Immune-mediatedAutoimmune hemolytic anemia (warm/cold), transfusion reactions, hemolytic disease of the newborn, drug-induced
MicroangiopathicHUS, TTP, DIC, defective cardiac valves
InfectionsMalaria, babesiosis
Physical/mechanical traumaMarathon running, bongo drumming
Toxic/chemical injurySnake venom, oxidant drugs
SequestrationHypersplenism

C. Decreased Red Cell Production (Hypoproliferative)

At least 75% of all anemia cases are hypoproliferative. - Harrison's Principles of Internal Medicine 22E
SubcategoryExamples
Nutritional deficienciesIron (most common overall), B12, folate, copper, vitamin C
Erythropoietin (EPO) deficiencyChronic kidney disease, anemia of inflammation, anemia of aging
Absence of red cell precursorsAplastic anemia, pure red cell aplasia (Diamond-Blackfan syndrome), parvovirus B19 infection
Marrow replacement (myelophthisis)Granulomatous disease, malignant infiltration, infections
Stem cell defectsAcute/chronic leukemia, myelodysplastic syndrome (MDS)
Immune-mediated progenitor injuryAplastic anemia (autoimmune T-cell attack)
Inherited genetic defectsFanconi anemia, telomerase defects

Summary Table

Classification ApproachKey TestSubtypes
Morphologic (MCV)MCV on CBCMicrocytic, Normocytic, Macrocytic
PathophysiologicReticulocyte countBlood loss, Hemolysis, Underproduction
In practice, both approaches are used together: the MCV guides the initial differential, while the reticulocyte count confirms the mechanism. The peripheral blood smear integrates both approaches and often provides the single most diagnostic piece of information. - Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 594; Goldman-Cecil Medicine, p. 1666-1667

Discuss the etiology, clinical features, investigations, and management of iron deficiency anemia. And also explain with why

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
I now have all the data I need for a thorough, well-explained answer. Let me compile it.

Iron Deficiency Anemia (IDA): A Complete Discussion

Iron deficiency anemia is the most common nutritional disorder in the world and the leading cause of anemia globally - affecting roughly 10% of people in high-resource countries and 25-50% in lower-resource settings. - Robbins & Kumar Basic Pathology, p. 393

Understanding Iron Metabolism First (the "Why" Foundation)

Before discussing IDA, you must understand normal iron biology - because every feature of IDA follows logically from it.
Total body iron distribution:
PoolMales (mg)Females (mg)
Hemoglobin (functional)21001750
Myoglobin + enzymes350300
Storage (ferritin/hemosiderin)1000400
Total~3450~2450
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 612
Key facts:
  • Iron is lost at 1-2 mg/day through shed mucosal and skin cells. There is no regulated excretion pathway - so the body tightly controls absorption to compensate.
  • The normal diet contains 10-20 mg/day. Only ~20% of heme iron and 1-2% of non-heme iron is absorbed - so the average Western diet (meat-rich) provides just enough.
  • Hepcidin (liver-produced) is the master regulator: it degrades ferroportin on intestinal cells, blocking iron export into blood. When iron stores are low, hepcidin falls, ferroportin increases, and more iron is absorbed. When inflammation occurs, hepcidin rises (IL-6 stimulus) - causing functional iron deficiency (the mechanism of anemia of chronic disease).
Iron transport: Absorbed Fe³⁺ binds transferrin in plasma (normally ~33% saturated = serum iron ~100-120 µg/dL). Transferrin delivers iron to erythroid precursors in bone marrow via receptor-mediated endocytosis.
Storage: Ferritin (soluble, in macrophages/hepatocytes) is the main storage form. Hemosiderin (degraded ferritin aggregates, stains blue with Prussian blue) forms in iron overload. Serum ferritin directly reflects storage iron.

Etiology (Causes of Iron Deficiency)

Iron deficiency results from four mechanisms:

1. Dietary Lack

  • Rare in meat-eating populations (heme iron is highly bioavailable)
  • Common in:
    • Infants (breast milk has only ~0.3 mg/L iron; very low bioavailability in cow's milk)
    • Vegans/vegetarians (non-heme iron in plants is poorly absorbed; inhibited further by tannins in tea, phosphates, oxalates, phytates)
    • Elderly with restricted diets (poor dentition, limited income)
    • Low-resource countries where most dietary iron is non-heme plant iron
Why? Non-heme iron must be in Fe²⁺ (ferrous) form for absorption. Tannins, carbonates, and phytates stabilize Fe³⁺ (ferric), making it non-absorbable. Ascorbic acid does the opposite - it reduces Fe³⁺ to Fe²⁺ and thus enhances absorption.

2. Impaired Absorption

  • Celiac disease / tropical sprue - autoimmune damage to duodenal villi where iron is absorbed
  • Gastrectomy - reduced acid production (acidity is needed to reduce Fe³⁺ → Fe²⁺ and release iron from food) + rapid gastric emptying bypasses the duodenum
  • H. pylori infection - decreases iron absorption + produces microerosions that bleed
  • Proton pump inhibitors - reduce gastric acid, impairing non-heme iron reduction
  • Dietary inhibitors: tannins (tea), phytates (cereals), phosphates, calcium

3. Increased Requirements

  • Infants and young children - rapid growth demands more iron than milk provides
  • Adolescents - growth spurts
  • Premenopausal women - menstruation (normal loss ~30-40 mL blood/cycle = ~15-20 mg iron)
  • Pregnancy - fetal demands and expanded maternal blood volume increase iron needs to ~5-6 mg/day in the 2nd and 3rd trimesters; this exceeds diet alone

4. Chronic Blood Loss (Most Common Cause in Developed Countries)

  • GI tract (most common in adult men and postmenopausal women):
    • Peptic ulcer disease
    • Colorectal cancer / polyps
    • Angiodysplasia
    • Hookworm infestation (major cause in tropical regions - each worm causes ~0.03 mL blood loss/day)
    • NSAIDs causing gastric erosions
  • Genitourinary tract: menorrhagia, uterine fibroids, endometrial carcinoma
  • Pulmonary: pulmonary hemosiderosis (rare)
  • Iatrogenic: repeated phlebotomy, hemodialysis
Critical clinical point: Iron deficiency in an adult male or postmenopausal female must be attributed to GI blood loss until proven otherwise - missing this can mean missing colorectal cancer. - Robbins, Cotran & Kumar, p. 614

Stages of Iron Deficiency (the "Why" for Lab Changes)

IDA develops in three sequential stages:
StageWhat HappensLab Findings
1. Pre-latent (Storage depletion)Storage iron is consumed; functional iron maintained↓ Serum ferritin; bone marrow iron absent; Hb normal
2. Latent (Iron-deficient erythropoiesis)Storage gone; serum iron begins to fall; RBC production impaired but Hb still near-normal↓ Serum iron, ↓ transferrin saturation, ↑ TIBC, ↑ free erythrocyte protoporphyrin; Hb still normal
3. Iron deficiency anemiaHb synthesis insufficient; overt anemia with microcytic, hypochromic RBCsAll above + ↓ Hb/Hct, microcytosis, hypochromia, poikilocytosis

Clinical Features

A. Symptoms of Anemia (from reduced O₂ delivery)

  • Fatigue, weakness, easy fatigability - tissues are hypoxic
  • Dyspnea on exertion - compensatory tachypnea
  • Palpitations, tachycardia - compensatory increased cardiac output
  • Headache, dizziness, poor concentration - cerebral hypoxia
  • Pallor - reduced hemoglobin in superficial vessels

B. Signs Specific to Iron Deficiency

These arise because iron is not just in hemoglobin - it is in cytochromes, catalase, myoglobin, and other enzymes throughout the body. Depletion of these iron-containing enzymes causes:
SignWhy it occurs
Koilonychia (spoon-shaped nails)Iron-containing enzymes in nail matrix are depleted → soft, brittle nails that flatten then concave
Alopecia (hair loss)Hair follicle cells have high turnover; iron-dependent enzymes for DNA synthesis and mitochondrial function are depleted
Atrophic glossitis (smooth, sore tongue)Tongue epithelial cells divide rapidly and depend on iron-containing enzymes; loss leads to papillary atrophy
Angular stomatitis / cheilitisIron deficiency impairs mucosal cell regeneration at lip corners
Dysphagia / esophageal websIron depletion in upper esophageal mucosa → postcricoid webs (Plummer-Vinson / Paterson-Kelly syndrome, the triad of: microcytic anemia + atrophic glossitis + esophageal web)
PicaCraving for non-food items (clay = geophagia, ice = pagophagia, flour, starch). Mechanism unclear but may relate to iron depletion in the CNS dopaminergic pathways
Pagophagia (compulsive ice eating)Most specific form of pica for IDA
Reduced gastric acidMucosal iron enzymes depleted → can worsen absorption (vicious cycle)
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 615

Investigations

1. Complete Blood Count (CBC)

ParameterFinding in IDAWhy
Hemoglobin↓ (moderate-severe)Less hemoglobin synthesized per cell
MCV↓ < 80 fL (microcytic)Less Hb → smaller cells
MCHLess hemoglobin per cell
MCHC↓ (hypochromic)Dilute hemoglobin content per volume
RDW↑ (anisocytosis)Mixed population of old normal + new small cells
PlateletsOften ↑ (reactive thrombocytosis)Iron deficiency stimulates TPO-like pathways; common finding
Reticulocyte countLow (inappropriately for degree of anemia)Marrow lacks substrate (iron) to produce RBCs

2. Peripheral Blood Smear (PBS)

The most informative single test:
  • Microcytes - small RBCs
  • Hypochromia - enlarged central pallor (> 1/3 cell diameter); hemoglobin visible only as a thin rim
  • Pencil cells / cigar cells - elongated, small RBCs (characteristic of IDA)
  • Anisocytosis - varying cell sizes
  • Poikilocytosis - varying shapes
IDA peripheral blood smear showing hypochromic microcytic RBCs with enlarged central pallor and a normal WBC
IDA peripheral blood smear: note the pale, small red cells with a broad central pallor. A transfused, fully hemoglobinized cell is seen in contrast. - Robbins, Cotran & Kumar, p. 615

3. Iron Studies

TestIDANormalAnemia of Chronic Disease (for comparison)
Serum iron100-120 µg/dL
TIBC (total iron-binding capacity)300-350 µg/dL↓ or normal
Transferrin saturation↓ < 15%~33%
Serum ferritin↓ < 12 µg/L12-300 µg/L↑ (acute phase reactant)
Serum hepcidinNormal
Why TIBC rises in IDA: When iron is low, the liver produces more transferrin to "capture" what little iron is available. More empty transferrin in the blood = higher TIBC. In contrast, ferritin is an acute phase reactant, so it can be falsely normal or elevated in IDA with co-existing infection/inflammation.
Why ferritin is the best screening test: It directly reflects storage iron. A ferritin < 12 µg/L is virtually diagnostic of IDA, and a level < 30 µg/L is highly sensitive even without overt anemia.

4. Bone Marrow Examination (rarely needed)

  • Absence of Prussian blue-staining iron in macrophages = diagnostic gold standard for IDA
  • Increased erythroid precursors (erythroid hyperplasia)
  • Used when diagnosis is uncertain (e.g., co-existing inflammation elevating ferritin)

5. Other Tests (to identify the cause)

  • Stool occult blood test - GI bleeding
  • Colonoscopy / upper endoscopy - mandatory in all adult males and postmenopausal women with IDA
  • Duodenal biopsy - to rule out celiac disease
  • H. pylori testing - serology or stool antigen
  • Capsule endoscopy - if all endoscopic procedures are unrevealing
  • Reticulocyte count - will rise within 5-7 days of iron supplementation (confirming diagnosis)

Management

Management of IDA has two goals: (1) treat the anemia and (2) identify and correct the underlying cause.

Step 1: Identify and Treat the Underlying Cause

  • This is the most important step. Replacing iron without finding the source of loss is inadequate - especially if bleeding is from a GI cancer.
  • Treat celiac disease (gluten-free diet), H. pylori, control menorrhagia, etc.

Step 2: Iron Supplementation

A. Oral Iron (First-line)

  • Ferrous sulfate 325 mg (contains 65 mg elemental iron) once daily on an empty stomach
  • Alternatively: ferrous fumarate, ferrous gluconate
  • Why empty stomach? Gastric acid enhances Fe³⁺ → Fe²⁺ reduction and absorption. Food, antacids, calcium, and PPIs all reduce absorption.
  • Why ferrous (Fe²⁺) not ferric (Fe³⁺)? Only Fe²⁺ is transported by DMT1; Fe³⁺ must first be reduced - so ferrous salts have higher bioavailability.
  • Avoid timed-release preparations - iron is released beyond the duodenum where absorption is minimal.
  • Vitamin C (ascorbic acid) co-administration enhances absorption by keeping iron in the reduced Fe²⁺ state.
Expected response:
Dose (mg/day elemental iron)Estimated absorptionHb rise per day
35 mg40% (~14 mg)0.7 g/L/day
105 mg24% (~25 mg)1.4 g/L/day
195 mg18% (~35 mg)1.9 g/L/day
  • Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 928
Timeline:
  • 5-7 days: reticulocytosis peaks (marrow responds)
  • 2-4 weeks: Hb begins to rise significantly
  • 1-2 months: Hb normalizes
  • 3-6 months: continue iron to replenish stores after Hb is normal (stores replenish slowly at ~100 mg/month)
Side effects of oral iron (due to unabsorbed iron in the gut):
  • Constipation, dark stools
  • Nausea, epigastric discomfort
  • Can be reduced by taking with food (at expense of some absorption)

B. Intravenous (IV) Iron (Second-line)

Used when:
  • Oral iron is not tolerated (severe GI side effects)
  • Oral iron is ineffective (malabsorption, celiac disease, post-gastrectomy)
  • Rapid repletion is needed (perioperative, heart failure, inflammatory bowel disease)
  • Ongoing blood loss exceeds oral replenishment capacity
PreparationDosing
Ferric carboxymaltose750 mg × 2 doses, ≥7 days apart
Iron sucrose100-300 mg × multiple doses
Ferric gluconate125-250 mg × multiple doses
Low-molecular-weight iron dextranSingle dose up to 1000 mg
Ferumoxytol510 mg × 2 doses, 3-8 days apart
Iron isomaltosideSingle dose 1000 mg (if ≥50 kg)
  • Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 930
Why IV iron bypasses the gut limitation? Oral iron absorption is limited to ~1-2 mg/day when stores are full (hepcidin rises as iron is replenished, blocking ferroportin). IV iron delivers iron directly to transferrin and the reticuloendothelial system, bypassing the hepcidin-ferroportin regulation.
Caution with iron dextran: Risk of anaphylaxis (highest among IV iron preparations); give a test dose and monitor for 1 hour. Switch to other preparations (iron sucrose, ferric gluconate) which have lower anaphylaxis risk.

C. Blood Transfusion (Reserved for severe/symptomatic cases)

  • Only for Hb < 7-8 g/dL with hemodynamic instability, severe symptoms, or cardiac compromise
  • Does not address the underlying deficiency - iron supplementation is still required

D. Dietary Advice

  • Increase heme iron (red meat, poultry, liver, oysters)
  • Avoid tea/coffee with meals (tannins inhibit absorption)
  • Add vitamin C-rich foods with iron-containing meals
  • Cook in cast-iron pots (small but real effect)

Summary: The "Why" Chain in IDA

Cause (blood loss / low intake / malabsorption / increased need)
       ↓
Storage iron depleted (ferritin ↓, Prussian blue staining absent in marrow)
       ↓
Serum iron ↓ → Liver makes more transferrin → TIBC ↑ → Transferrin saturation ↓
       ↓
Hepcidin ↓ (iron stores low → less HFE signaling to liver)
       ↓
Insufficient iron delivered to erythroid precursors → protoporphyrin accumulates
       ↓
Less hemoglobin synthesized per RBC → smaller, paler cells (microcytic, hypochromic)
       ↓
Iron-containing enzymes in all tissues depleted → koilonychia, glossitis, pica, esophageal webs

Plummer-Vinson syndrome or Patterson-Brown-Kelly or sideropenic dysphagia develops in long-standing iron deficiency. – Iron deficiency (microcytic hypochromic) anemia – Atrophic glossitis – Esophageal/post-cricoid webs resulting in dysphagia for solids than liquids. The web can be demonstrated either by endoscopy or by barium swallow – These patients have increased risk of squamous cell carcinoma of pharynx and esophagus. Treatment of Plummer-Vinson syndrome: Administration of iron. Severe obstruction by the web may require dilatation. Regular upper GI endoscopy may be required for the early detection of cancers. Explain with why

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Loading Image
Excellent. I now have all the material needed for a thorough "explained with why" answer. Let me compile it now.

Plummer-Vinson Syndrome (Patterson-Brown-Kelly / Sideropenic Dysphagia)

Explained with the "Why" at every step


What Is It?

Plummer-Vinson syndrome is defined by the classic triad of:
  1. Iron deficiency (microcytic, hypochromic) anemia
  2. Atrophic glossitis
  3. Postcricoid / upper esophageal webs → dysphagia for solids more than liquids
It is a rare condition, predominantly affecting middle-aged women (40-70 years), with a strong female preponderance (F:M ratio ~10:1), and historically more common in Scandinavian populations. - Yamada's Textbook of Gastroenterology, 7th ed.; KJ Lee's Essential Otolaryngology
Why predominantly women? Women of reproductive age have chronically lower iron stores than men (storage iron ~400 mg vs ~1000 mg in men) due to menstrual blood loss and pregnancy demands. This chronic negative iron balance over decades predisposes to the tissue depletion required for this syndrome to develop.

The Central Mechanism: Everything Flows from Iron Depletion

The key to understanding every feature of this syndrome is this:
Iron is not just in hemoglobin. It is an essential cofactor for:
  • Cytochromes (mitochondrial electron transport chain - cellular energy production)
  • Iron-sulfur cluster enzymes (multiple metabolic pathways)
  • Ribonucleotide reductase (DNA synthesis)
  • Collagen hydroxylases (connective tissue formation)
  • Mucosal enzymes (governing epithelial cell turnover and repair)
When iron stores are severely and chronically depleted, all rapidly dividing, high-turnover tissues suffer - and the gastrointestinal tract's mucosal lining (tongue, pharynx, esophagus, stomach) is one of the fastest-dividing tissues in the body.
Chronic iron deficiency
        ↓
Depletion of iron-containing enzymes in mucosal cells
        ↓
Impaired cellular energy production (cytochromes) + impaired DNA synthesis
        ↓
Mucosal atrophy throughout the upper GI tract
        ↓
Glossitis + esophageal web formation + achlorhydria

Feature 1: Iron Deficiency Anemia (Microcytic, Hypochromic)

Why microcytic? When iron is unavailable, erythroid precursors in the marrow cannot synthesize enough hemoglobin. With less hemoglobin content, cells are smaller (MCV < 80 fL) and paler (MCHC reduced).
Why hypochromic? The zone of central pallor on the red cell is enlarged beyond the normal 1/3 diameter because hemoglobin fills only the periphery - the classic peripheral smear finding with "pencil cells."
Lab hallmarks:
  • ↓ Serum iron
  • ↓ Serum ferritin (< 12 µg/L)
  • ↑ TIBC (liver makes more transferrin to scavenge scarce iron)
  • ↓ Transferrin saturation (< 15%)
  • ↓ Hepcidin (low iron stores → less HFE-mediated signaling to liver → hepcidin falls)

Feature 2: Atrophic Glossitis

What it looks like: The tongue appears smooth, beefy red or pale, with loss of normal filiform and fungiform papillae ("bald tongue"). It may be sore or burning.
Why does this happen?
The tongue's surface is covered by a rapidly renewing squamous epithelium (turnover every 5-7 days). This rapid cell division requires:
  • Iron for ribonucleotide reductase (makes deoxyribonucleotides for DNA replication)
  • Iron for cytochromes (cellular energy to fuel division)
  • Iron for collagen hydroxylases (maintaining mucosal architecture)
When iron is depleted, the tongue epithelium cannot renew itself fast enough. Papillae atrophy and disappear. The result is the characteristic smooth, atrophic tongue.
Why the tongue specifically? The tongue, along with the rest of the oropharyngeal/esophageal mucosa, has one of the highest epithelial turnover rates in the body. These tissues are therefore the first to show iron-deprivation effects, even before anemia becomes severe.

Feature 3: Esophageal / Postcricoid Webs → Dysphagia for Solids

What are esophageal webs?

Esophageal webs are thin, shelf-like folds of mucosa and submucosa that project into the esophageal lumen, most commonly from the anterior wall of the upper/proximal esophagus, just below the cricopharyngeal muscle (the postcricoid region). They are eccentric (off-center), thin, gray, and smooth on endoscopy.
Webs can be present in up to 5% of asymptomatic individuals. In Plummer-Vinson, they are symptomatic because they reduce luminal diameter - dysphagia occurs when the diameter narrows to less than 12 mm. - Yamada's Textbook of Gastroenterology, 7th ed.

Why do webs form in iron deficiency?

The exact pathogenesis is not fully understood, but the most accepted mechanism is:
  1. Iron-dependent enzymes in the upper esophageal mucosa (cytochromes, collagen hydroxylases) become depleted in chronic iron deficiency
  2. This leads to mucosal atrophy, submucosal inflammation, and defective repair of the postcricoid region
  3. Chronic mucosal damage triggers fibrous healing and web formation - the web is essentially a fold of fibrosed atrophic mucosa
  4. Additionally, degeneration of esophageal muscle has been described, possibly contributing to motor dysfunction at the cricopharyngeal level
Why solids more than liquids? Liquids can flow around or through even a narrow, eccentric lumen. Solid food boluses cannot deform enough to squeeze through a luminal diameter of < 12 mm. The dysphagia is therefore predominantly for solids, characteristically intermittent initially and progressive over time.
Why upper/postcricoid region? The postcricoid area is under the greatest mechanical stress during swallowing (high-pressure zone at the cricopharyngeal sphincter) and has a specific mucosal anatomy that makes it vulnerable to iron-depletion injury. - KJ Lee's Essential Otolaryngology

Associated mucosal features

  • Angular cheilitis (fissures at mouth corners) - iron-depleted mucosa at the lip commisures
  • Koilonychia (spoon nails) - iron-depleted nail matrix enzymes
  • Achlorhydria - iron depletion in gastric parietal cell enzymes reduces acid secretion (and in turn, worsens iron absorption - a vicious cycle)
  • Hoarseness - pharyngeal/laryngeal mucosal involvement
  • Atrophic gastritis, diarrhea - widespread upper GI mucosal atrophy

Investigations

To Demonstrate the Web

1. Barium swallow (videofluoroscopy) - most sensitive
This is the first-line and most sensitive imaging test for esophageal webs. On the barium study, the web appears as a thin, shelf-like filling defect projecting from the anterior wall of the upper esophagus.
Barium swallow showing a proximal esophageal web (thin transverse band narrowing the lumen) in Plummer-Vinson syndrome
Barium swallow showing a proximal esophageal web in Plummer-Vinson syndrome - note the thin transverse band causing luminal narrowing. - Cummings Otolaryngology, p. 1242
2. Upper endoscopy (esophagoscopy)
The web appears as a smooth, thin, gray, eccentric lesion on the anterior esophageal wall. Important caveats:
  • Webs are located so proximally that routine passage of the endoscope through the upper esophageal sphincter (UES) can fracture the web before it is seen - so the endoscope must be introduced under direct visualization
  • The web may be missed if the operator is not looking for it
  • Endoscopy is also used to perform biopsy to exclude carcinoma and for dilatation if needed
Why endoscopy is essential (not just barium): Barium swallow shows the anatomical web but cannot biopsy it. Endoscopy allows both visualization and tissue sampling - critical given the malignancy risk.

For Iron Deficiency

  • CBC: microcytic (↓ MCV), hypochromic (↓ MCH, ↓ MCHC), ↑ RDW
  • Serum ferritin (< 12 µg/L), ↓ serum iron, ↑ TIBC, ↓ transferrin saturation
  • Peripheral smear: hypochromic microcytes, pencil cells

Cancer Risk: Squamous Cell Carcinoma

Patients with Plummer-Vinson syndrome have a significantly increased risk of squamous cell carcinoma (SCC) of the:
  • Pharynx (particularly the hypopharynx / postcricoid region)
  • Upper esophagus
Other risk factors for esophageal SCC include: alcohol, smoking, achalasia, caustic ingestion, hot beverages, and betel nut chewing - and Plummer-Vinson syndrome sits alongside these. - Fischer's Mastery of Surgery 8th ed.; Cummings Otolaryngology

Why does Plummer-Vinson predispose to SCC? (The key "why")

This is a multi-step mechanism:
Step 1 - Chronic mucosal atrophy and inflammation: Iron depletion causes sustained mucosal atrophy in the postcricoid region. Chronically atrophic, hypoxic epithelium with impaired DNA repair (iron-dependent ribonucleotide reductase is depleted) accumulates DNA damage over years.
Step 2 - Impaired DNA repair: Iron is a cofactor for several DNA repair enzymes. When iron is chronically deficient, these enzymes are inadequate, and DNA mismatches and strand breaks are not corrected efficiently. This allows mutations to accumulate.
Step 3 - Chronic inflammation: The atrophic, iron-deprived mucosa is more susceptible to microtrauma from food boluses and secondary inflammation. Chronic inflammation is itself a carcinogenic milieu (generating reactive oxygen species, promoting cell proliferation).
Step 4 - The web itself as a physical risk factor: The web creates a zone of food stasis and repeated mechanical trauma just proximal to the obstruction. Retained food material causes prolonged contact of dietary carcinogens (e.g., from alcohol, tobacco, food additives) with the atrophic postcricoid mucosa.
The result: SCC typically arises in the postcricoid / hypopharyngeal region - the same site as the web and mucosal atrophy.
Important note: The cancer risk justifies regular upper GI endoscopic surveillance, even after the web is treated, because the underlying mucosal vulnerability persists until iron stores are fully normalized.

Treatment: Explained with Why

1. Iron Supplementation (Primary Treatment)

Ferrous sulfate 325 mg orally once daily (or ferrous fumarate/gluconate) for 3-6 months.
Why this works:
  • Restores iron to mucosal enzymes → atrophic mucosa regenerates (glossitis and cheilitis resolve)
  • Removes the inflammatory stimulus that drove web formation
  • Iron supplementation alone can resolve dysphagia in many patients - the web may soften and retract as the atrophic mucosa heals - Yamada's Textbook of Gastroenterology
Monitor: Reticulocyte count rises in 5-7 days (confirming response). Hb normalizes in 6-8 weeks. Continue iron for 3-6 months after Hb is normal to replenish stores.

2. Web Dilatation (for significant obstruction)

When the web causes severe or persistent dysphagia despite iron therapy:
  • Bougie dilation (Savary-Gilliard bougies) or balloon dilation at endoscopy
  • This mechanically disrupts the web and restores luminal patency
  • The procedure is curative in most cases
  • Importantly, passage of the endoscope itself sometimes fractures the web inadvertently
Why dilatation is safe here: Unlike fibrotic strictures from eosinophilic esophagitis or caustic injury, Plummer-Vinson webs are thin mucosal folds with little fibrosis - they disrupt easily and do not recur if iron deficiency is corrected.

3. Regular Upper GI Endoscopic Surveillance

  • Indicated because of the elevated SCC risk
  • Frequency: typically every 1-3 years depending on risk factors and clinical context
  • Allows: early detection of dysplasia or carcinoma at the postcricoid / hypopharyngeal region
  • Biopsy of any suspicious area is mandatory
Why this matters: SCC of the hypopharynx/upper esophagus is potentially curable if caught early (stage I/II), but carries a poor prognosis when detected late. Regular surveillance converts this risk into an opportunity for early intervention.

Summary: The Complete "Why" Chain

Chronic iron deficiency
          ↓
↓ Iron-containing enzymes in all high-turnover tissues
          ↓
┌─────────────────────────────────────────────────┐
│ Bone marrow: ↓ Hb synthesis → microcytic anemia │
│ Tongue: mucosal atrophy → glossitis             │
│ Esophagus: mucosal atrophy → web formation      │
│ Nails: matrix enzyme loss → koilonychia         │
│ Stomach: parietal cell enzymes ↓ → achlorhydria │
└─────────────────────────────────────────────────┘
          ↓
Esophageal web (postcricoid) → narrow lumen (< 12 mm)
→ Dysphagia for solids > liquids
          ↓
Chronic mucosal atrophy + impaired DNA repair + food stasis
→ ↑ Risk of postcricoid / hypopharyngeal SCC
          ↓
Treatment: Iron → restore mucosal integrity
           Dilatation → relieve obstruction
           Endoscopy surveillance → detect cancer early
  • Sources: Yamada's Textbook of Gastroenterology 7e; Cummings Otolaryngology Head & Neck Surgery; KJ Lee's Essential Otolaryngology; Fischer's Mastery of Surgery 8e; Robbins, Cotran & Kumar Pathologic Basis of Disease
This is a shared conversation. Sign in to Orris to start your own chat.